Table 3.
Follow-up
Baseline serum creatinine |
p | |||||
---|---|---|---|---|---|---|
<1.0 mg/dl | 1.01–1.5 mg/dl | 1.51–2.0 mg/dl | 2.01–3.0 mg/dl | >3.0 mg/dl | ||
Patients | 22 | 23 | 16 | 12 | 13 | |
Follow-up, months | 133±60 | 122±64 | 130±67 | 130±59 | 71±60 | 0.04 |
CR | 19 (86%) | 12 (52%) | 3 (19%) | 3 (25%) | 0 (0%) | <0.0001 |
Time to CR, months | ||||||
Median | 6.3 | 12.3 | 23.3 | 18.3 | – | 0.33 |
Range | 1.3–56.5 | 2.3–20.3 | 8.3–54.0 | 7.5–37.5 | – | |
Status at last follow-up | ||||||
ESRD | 2 (9%) | 3 (13%) | 6 (38%) | 7 (58%) | 4 (31%) | 0.01 |
ESRD/death | 3 (14%) | 4 (17%) | 1 (6%) | 1 (8%) | 6 (46%) | 0.04 |
Death | 0 (0%) | 4 (17%) | 3 (19%) | 0 (0%) | 2 (15%) | 0.16 |
Stable renal function | 17 (77%) | 12 (52%) | 6 (38%) | 4 (33%) | 1 (8%) | 0.001 |
CR = Complete remission.